Clinical Trial Update: A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265

View source ↗

Summary

This clinical trial update reports follow-up data for patients with HBeAg-positive chronic hepatitis B treated with Pegasys (peginterferon alfa-2a) in study ML2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Status: COMPLETED